Ranbaxy Laboratories Lipitor Bloomberg News (1/26, Gale, Schoenberg) reports, BBC News (1/26) adds. “The legal proceedings do not affect the US sale of Ranbaxy’s generic version of the best-selling drug in the world, cholesterol” medications “Lipitor [atorvastatin].” Moreover, “the filing by the Justice Department on behalf of the FDA must be approved by a [...]
